BCL2 and cancer: ROS accumulation in cancer cells causes nitration and inactivation of PP2A, which interferes with the interaction of Bcl-2 with the PP2A catalytic core, leading to increased phosphorylation and antiapoptotic activity of Bcl-2 [38].